RETOS 2017

Retos Colaboration 2017 project completion

Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer  in a blood sample. The Aniling -led project uses patented GEUS …

Aniling Management

Farmabiotec reports Aniling achievements

The health biotechnology magazine Farmabiotec reports on Aniling’s late achivements. Farmabiotec goes through Aniling’s IVD tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy and highlights their recent CE …

Aniling in Expansion

Expansion reports Aniling achievements

Expansión newspaper explains the company’s latest milestone: Aniling obtains CE marking for three in vitro tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. News written by Gabriel Trindade …

Aniling has reached the CE Mark for GEUS-CLL

We are very proud to announce that Aniling has reached the CE Mark for our first product, GEUS-CLL, a first-in-class IVD medical device to support the diagnosis, prognosis, treatment selection …